Robert Hershberg

This inventor holds 17 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 7 EPO patents, primarily in Inflammatory Bowel Disease. Top assignees: Ventirx Pharmaceuticals, Inc., Corixa Corporation, Array Biopharma Inc.. Active years: 2008-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Hershberg. Retrieved from https://idiyas.com/inventor/robert-hershberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 7)

% Patents Active = 35.3

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 12)

Average Co-Inventor Count = 3.9

ph-index = 6

Forward Citations = 93(Granted Patents)

Company Filing History:

9 out of 10

Ventirx Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2008-2021

Loading Chart...

Areas of Expertise:

Inflammatory Bowel Disease

Therapy

Diagnosis

Antibody-Dependent Cellular Cytotoxicity

Toll-Like Receptor Modulators

Benzoazepines

Agonist Formulations

Cellular Immunotherapy

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10981978 - Compositions and methods for the therapy and diagnosis of Inflammatory Bowel Disease (2021-04-20),

2. 10457722 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease (2019-10-29),

3. 10016440 - Methods of enhancing antibody-dependent cellular cytotoxicity (2018-07-10),

4. 10011650 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease (2018-07-03),

5. 9868779 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease (2018-01-16),

6. 9718796 - Substituted benzoazepines as toll-like receptor modulators (2017-08-01),

7. 9655904 - Substituted benzoazepines as toll-like receptor modulators (2017-05-23),

8. 9290543 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease (2016-03-22),

9. 9242964 - Substituted benzoazepines as toll-like receptor modulators (2016-01-26),

10. 9216192 - Toll-like receptor agonist formulations and their use (2015-12-22),

11. 9175046 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease (2015-11-03),

12. 9126940 - Substituted benzoazepines as toll-like receptor modulators (2015-09-08),

13. 8691809 - Substituted benzoazepines as toll-like receptor modulators (2014-04-08),

14. 8524702 - Substituted benzoazepines as toll-like receptor modulators (2013-09-03),

15. 8318901 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease (2012-11-27),

Title: Top Inventor in Seattle, WA

Introduction: Jordin T. Kare is a prominent inventor known for his contributions to various fields of technology and innovation.

Latest Patents: His recent patents include advancements in aerospace technology and energy systems.

Career Highlights: Jordin has had a distinguished career, with numerous accolades recognizing his innovative work.

Collaborations: He has collaborated with leading companies and research institutions to push the boundaries of technology.

Conclusion: Jordin T. Kare continues to be a significant figure in the world of invention, inspiring future generations of innovators.

Profile summary based on public USPTO records.